» Articles » PMID: 30673717

Classification of Patients with Bipolar Disorder Using K-means Clustering

Overview
Journal PLoS One
Date 2019 Jan 24
PMID 30673717
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Bipolar disorder (BD) is a heterogeneous disorder needing personalized and shared decisions. We aimed to empirically develop a cluster-based classification that allocates patients according to their severity for helping clinicians in these processes.

Methods: Naturalistic, cross-sectional, multicenter study. We included 224 subjects with BD (DSM-IV-TR) under outpatient treatment from 4 sites in Spain. We obtained information on socio-demography, clinical course, psychopathology, cognition, functioning, vital signs, anthropometry and lab analysis. Statistical analysis: k-means clustering, comparisons of between-group variables, and expert criteria.

Results And Discussion: We obtained 12 profilers from 5 life domains that classified patients in five clusters. The profilers were: Number of hospitalizations and of suicide attempts, comorbid personality disorder, body mass index, metabolic syndrome, the number of comorbid physical illnesses, cognitive functioning, being permanently disabled due to BD, global and leisure time functioning, and patients' perception of their functioning and mental health. We obtained preliminary evidence on the construct validity of the classification: (1) all the profilers behaved correctly, significantly increasing in severity as the severity of the clusters increased, and (2) more severe clusters needed more complex pharmacological treatment.

Conclusions: We propose a new, easy-to-use, cluster-based severity classification for BD that may help clinicians in the processes of personalized medicine and shared decision-making.

Citing Articles

Functional recovery prediction during rehabilitation after rotator cuff tears by decision support system.

Adomaviciene A, Daunoraviciene K, Kazakeviciute-Januskeviciene G, Bausys R PLoS One. 2024; 19(3):e0296984.

PMID: 38527037 PMC: 10962824. DOI: 10.1371/journal.pone.0296984.


LRFMV: An efficient customer segmentation model for superstores.

Mahfuza R, Islam N, Toyeb M, Emon M, Chowdhury S, Alam M PLoS One. 2022; 17(12):e0279262.

PMID: 36538513 PMC: 9767363. DOI: 10.1371/journal.pone.0279262.


Patterns of patients with polypharmacy in adult population from Korea.

Shin W, Go T, Kang D, Lee S, Lee W, Kim S Sci Rep. 2022; 12(1):18073.

PMID: 36302935 PMC: 9613698. DOI: 10.1038/s41598-022-23032-z.


STI epidemic re-emergence, socio-epidemiological clusters characterisation and HIV coinfection in Catalonia, Spain, during 2017-2019: a retrospective population-based cohort study.

Sentis A, Montoro-Fernandez M, Lopez-Corbeto E, Egea-Cortes L, Nomah D, Diaz Y BMJ Open. 2021; 11(12):e052817.

PMID: 34903544 PMC: 8672020. DOI: 10.1136/bmjopen-2021-052817.


Treatment selection using prototyping in latent-space with application to depression treatment.

Kleinerman A, Rosenfeld A, Benrimoh D, Fratila R, Armstrong C, Mehltretter J PLoS One. 2021; 16(11):e0258400.

PMID: 34767577 PMC: 8589171. DOI: 10.1371/journal.pone.0258400.


References
1.
Gomez-Benito J, Guilera G, Pino O, Rojo E, Tabares-Seisdedos R, Safont G . The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients. BMC Psychiatry. 2013; 13:127. PMC: 3667105. DOI: 10.1186/1471-244X-13-127. View

2.
Colom F, Vieta E, Martinez-Aran A, Garcia-Garcia M, Reinares M, Torrent C . [Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale]. Med Clin (Barc). 2002; 119(10):366-71. DOI: 10.1016/s0025-7753(02)73419-2. View

3.
Tatay-Manteiga A, Balanza-Martinez V, Bristot G, Tabares-Seisdedos R, Kapczinski F, Cauli O . Clinical staging and serum cytokines in bipolar patients during euthymia. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 77:194-201. DOI: 10.1016/j.pnpbp.2017.04.028. View

4.
Goi P, Bucker J, Vianna-Sulzbach M, Rosa A, Grande I, Chendo I . Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice. Braz J Psychiatry. 2015; 37(2):121-5. DOI: 10.1590/1516-4446-2014-1554. View

5.
Kapczinski F, Dias V, Kauer-SantAnna M, Brietzke E, Vazquez G, Vieta E . The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(8):1366-71. DOI: 10.1016/j.pnpbp.2009.07.027. View